Sprout Pharmaceuticals Puts Women in the Mood

Source: PharmaManufacturing.com

Jul 11, 2013


Call it “romantic persistence.” Positive results of a Phase 3 clinical trial have spurred a New Drug Application resubmission that may pay off for Sprout….and millions of women.

Sprout Pharmaceuticals, a Raleigh-based pharmaceutical company, has resubmitted the New Drug Application (NDA) for flibanserin, a treatment being evaluated for Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women. If approved, Sprout’s version of “Pink Viagra” would be the first FDA approved treatment for HSDD in pre-menopausal women. Read more

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments